Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
regorafenib
×
Clear all
Filters
2
NCT04776148
2026-02-05
MK-7902-017
Merck Sharp & Dohme LLC
Phase 3
Completed
563 enrolled
32 charts
NCT05064059
2025-09-17
MK-4280A-007
Merck Sharp & Dohme LLC
Phase 3
Completed
441 enrolled
24 charts